Critical Illness Recovery Center
Leaving the intensive care unit (ICU) after a serious illness is a hopeful time for many patients. But it also can pose unexpected challenges. Following treatment in the ICU, about 50 percent of patients experience post-intensive care syndrome (PICS). Symptoms include muscle weakness and balance issues, problems with thinking and memory, difficulty sleeping and depression.
A visit at the Critical Illness Recovery Center at National Jewish Health in Denver after you have been discharged from the hospital can:
- Determine if you are experiencing PICS symptoms
- Prevent future problems related to your illness from occurring
- Help you recover faster and more fully
Our center is a member of the Society of Critical Care Medicine’s Thrive Initiative, an international network of clinics that seeks to improve patient and family support after critical illness.
About Our Center
Every person’s recovery is different. Whether you or your loved ones require a single screening visit or comprehensive follow-up care, the Critical Illness Recovery Center at National Jewish Health offers coordinated, personalized treatment from a team of specialists committed to helping patients recover from critical illness. Our multidisciplinary team includes:
- Critical care specialists
- Occupational specialists
- Physical therapists
- Speech therapists
- Registered dietitians
- Social workers
- Neurologists
- Psychologists
- Neuropsychologists
- Sleep and insomnia specialists
We Also Provide:
- Follow-up care in partnership with your primary care doctor
- Answers to questions about medications
Doctors
-
Howard Saft, MD, MS
-
Joshua J. Solomon, MD
Clinical Trials
Idiopathic Pulmonary Fibrosis (IPF) & GERD
The purpose of this study is to measure and accurately identify the presence and severity of gastroesphageal reflux disease (GERD), commonly called acid reflux, in idiopathic pulmonary fibrosis (IPF) patients using the Supraglottic Index (SGI).
Learn More- ADRN-12/LEADS (Longitudinal Endotyping of Atopic Dermatitis Through Transcriptomic Skin Analysis)
- Atopic Dermatitis & Skin Infections
- BBT-877: Possible Treatment for Idiopathic Pulmonary Fibrosis
- BEACON-CF: Investigational mRNA Therapy for Cystic Fibrosis
- Biomarkers & Hypersensitivity Pneumonitis Progression
- Blood Test to Help Identify Cancer
- Can Pembrolizumab (MK3475) with SBRT Treatment Stop or Slow Non-Small Cell Lung Cancer?
- CHARM Study for Asthma
- Creating Asthma Measurements through the MORRE Study
- Effects of Pregnancy for Cystic Fibrosis Patients
- Extensive Stage Small Cell Lung Cancer Combination Treatment
- Healthy Adults Needed for Beryllium Disease Study
- Healthy People Needed for Sarcoidosis Research
- Identifying Characteristics and Patterns of Asthma
- ILD & Early Rheumatoid Arthritis
- Immune Pathways & Development of Sarcoidosis
- Improving Treatment for IPF
- Investigational Gene Therapy for Adults with CF
- Link Between Rheumatoid Arthritis & Lung Disease
- Lung Cancer & COVID Infection
- Lung Injury from Military Deployment
- Mineral Dust & Lung Disease
- MyAI Registry for People with Adrenal Insufficiency
- New Trial Medication for Pulmonary Arterial Hypertension
- NICE-CF: Colon Cancer Screening for adults with Cystic Fibrosis
- OCEAN Study for EGPA
- Potential New Treatment for Metastatic Lung Cancer
- Potential New Treatment for Metastatic Lung Cancer
- PRA023 for Systemic Sclerosis with Interstitial Lung Disease
- Predict and Prevent Lung Disease
- Predicting ILD from Hypersensitivity Pneumonitis
- Pulmonary Arterial Hypertension & increased dose of Opsumit
- Pulmonary Fibrosis & Genetic Factors
- RESOLVE-Lung Study for Pulmonary Sarcoidosis
- Silicosis Registry
- Skin Reactions to Cancer Immunotherapy
- Skin, Airway & Esophageal Epithelial Barriers in Youth
- SUNBEAM: Studying Allergy Development in Babies
- SUNRISE Trial for Oral Steroid Dependent Asthma
- Treating Deployment-Related Asthma with Supplements
- Understanding Allergy Development in Infants
- Understanding Reproductive Health Concerns in Men with CF
- Understanding Skin Problems from Eczema and Food Allergies
- XTMAB-16: A New Drug to Reduce Steroid Use in Sarcoidosis
Reasons to Choose National Jewish Health
- The leading respiratory hospital in the nation and the only one devoted fully to the treatment of respiratory and related illnesses
- Ranked #1 or #2 in Pulmonology by U.S. News & World Report for 26 consecutive years
- Ranked in the top 5% of hospitals in the nation by HCAHPS
- Physicians consistently recognized among the best in the nation by multiple services, including Best Doctors in America and Castle Connolly
- Among the top 6% of organizations funded for research by the NIH, providing patients access to hundreds of active clinical trials
- 124-year history of focus on care, research and education serving patients from around the world with lung, heart, immune and related disorders
Changing Gears and Adding Years: A Hot Rodder’s Recovery Story
Changing Gears and Adding Years: A Hot Rodder’s Recovery Story
Read More